Home/Senex Biotechnology/Karthik Gopalakrishnan

KG

Karthik Gopalakrishnan

Consultant, Corporate & Business Development

Senex Biotechnology

Therapeutic Areas

Oncology Inflammation Cardiovascular Diseases

Senex Biotechnology Pipeline

Drug	Indication	Phase
Senexin Program (Lead)	Prostate Cancer, Breast Cancer, Leukemia (treatment-resistant/metastatic)	Pre-clinical
Undisclosed Program 2	Cancer	Discovery
Undisclosed Program 3	Cancer	Discovery

Leadership Team at Senex Biotechnology

Igor B Roninson

Founder, President, Chief Scientific Officer, Chairman

Dennis Goldberg

Chief Executive Officer, Director

Chief Medical Officer

Mengqian (Max) Chen

Director of Research

View full Senex Biotechnology profile